
Image shows an activated microglial cell next to other cells in a mouse brain.
Image Credit: UCR/Kaul lab AI generated / Gemini
Scientific Frontline: Extended "At a Glance" Summary: MAPK14 and NeuroHIV
The Core Concept: A specific brain protein, MAPK14 (or p38α mitogen-activated protein kinase), has been identified as a critical driver of the inflammatory response that causes brain damage and cognitive impairment in long-term HIV infections, a condition known as neuroHIV.
Key Distinction/Mechanism: Unlike the viral infection itself, the damage is caused when MAPK14 is activated in microglial cells (the brain's resident immune cells) simply by exposure to a component of the HIV envelope (gp120), inducing a neurotoxic state that harms dendrites and synapses.
Major Frameworks/Components:
- Microglia: The brain's resident immune cells, which carry binding sites for the HIV envelope protein.
- MAPK14 (p38α): A gene and protein integral to inflammatory responses.
- HIV Envelope Protein gp120: The viral component that interacts with microglia to trigger the neurotoxic cascade.
- NeuroHIV Mouse Model (HIVgp120tg): A transgenic model expressing the HIV envelope protein, used to demonstrate that removing MAPK14 from microglia prevents brain injury.
.png)
.jpg)






.jpg)
_result.png)
.jpg)


